Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Beauty Consciousness
4.2.2 Growing Awareness About Physician Dispensed Cosmeceuticals
4.3 Market Restraints
4.3.1 High Cost of the Products
4.3.2 Lack of Trained and Skilled Professionals
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Skin Care
5.1.1.1 Anti-Ageing
5.1.1.2 Sunscreens
5.1.1.3 Other Skin Care Products
5.1.2 Eye Care
5.1.2.1 Prescription Drops
5.1.2.2 Artificial Tears
5.1.2.3 Other Eye Care Products
5.1.3 Hair Care
5.1.3.1 Hair Repair
5.1.3.2 Anti-dandruff
5.1.3.3 Other Hair care Products
5.1.4 Others
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East and Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East and Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allergan
6.1.2 Merz Pharma
6.1.3 INNOVATIVE SKINCARE
6.1.4 Obagi Cosmeceuticals LLC
6.1.5 SkinCeuticals International
6.1.6 JMSR, Inc.
6.1.7 CUSKIN.
6.1.8 Khiron Life Sciences Corp
6.1.9 La Roche-Posay


7 MARKET OPPORTUNITIES AND FUTURE TRENDS